Variables | P-value | Adjusted OR/RRa | 95%CI |
---|---|---|---|
Characteristics in relation to RPL* | |||
CAG < 20 | 0.000 | 3.012 | 1.648–5.504 |
SXCI | 0.002 | 63.064 | 4.381-907.785 |
Duration of stimulation | 0.022 | 0.866 | 0.798–0.983 |
Characteristics in relation to DOR** | |||
RPL group (participants in the case–control study, N = 131) | |||
Age | 0.000 | 1.891 | 1.341–2.665 |
AMH | 0.001 | 0.214 | 0.090–0.511 |
Control group (N = 126) | |||
CAG < 20 | 0.039 | 15.384 | 1.148-204.904 |
Age | 0.005 | 1.622 | 1.154–2.280 |
AMH | 0.001 | 0.026 | 0.003–0.210 |
RPL cohort (participants in the external validation cohort, N = 363) | |||
Age | 0.001 | 1.295 | 1.116–1.502 |
AMH | 0.000 | 0.104 | 0.045–0.237 |
AFC | 0.036 | 0.905 | 0.824–0.993 |
Characteristics in relation to blastocyst euploidy in patients with RPL*** | |||
RPL group (participants in the case–control study, N = 131) | |||
AFC | 0.000 | 1.336 | 1.164–1.532 |
RPL cohort (participants in the external validation cohort, N = 363) | |||
Age | 0.003 | 0.916 | 0.864–0.970 |
AFC | 0.000 | 1.189 | 1.122–1.261 |